Invesco Pharmaceuticals ETF (PJP) Price, Holdings, & News

ETF Overview

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund normally invests at least 90% of its total assets in common stocks that consists of the Index. The Fund's investment advisor is Invesco PowerShares Capital Management LLC.

Key Stats

• Today's Range: $78.73 to $79.26
• 50-Day Range: $74.59 to $86.61
• 52-Week Range: $72.25 to $89.87
• Volume: 29,622 shs
• Average Volume: 8,643 shs
• Market Capitalization: $233.51 million
• Assets Under Management: $235.29 million
• Dividend Yield: 1.15%
• Net Expense Ratio: 0.57%
• Aggregate Rating: Moderate Buy

PJP ETF - Frequently Asked Questions

How have PJP shares performed this year?

Invesco Pharmaceuticals ETF's stock was trading at $82.62 on January 1st, 2025. Since then, PJP shares have decreased by 4.2% and is now trading at $79.18.
View the best growth stocks for 2025 here.

Who are Invesco Pharmaceuticals ETF's major shareholders?

Top institutional investors of Invesco Pharmaceuticals ETF include Peak Asset Management LLC (4.49%), LPL Financial LLC (1.66%), GAMMA Investing LLC (1.22%) and Federation des caisses Desjardins du Quebec (0.94%).

How do I buy shares of Invesco Pharmaceuticals ETF?

Shares of PJP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Invesco Pharmaceuticals ETF own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Invesco Pharmaceuticals ETF investors own include NVIDIA (NVDA), Meta Platforms (META), Walt Disney (DIS), Affirm (AFRM), Advanced Micro Devices (AMD), Netflix (NFLX) and Pfizer (PFE).

Fund Details

• Issuer: Invesco
• Fund Name: Invesco Pharmaceuticals ETF
• Tax Classification: Regulated Investment Company
• Stock Exchange: NYSEARCA
• Current Symbol: NYSEARCA:PJP
• Inception Date: 6/23/2005
• Fund Manager: Peter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser
• Web: www.invescopowershares.com
• Phone: +1-800-9830903

Fund Focus

• Asset Class: Equity
• Benchmark: Dynamic Pharmaceutical Intellidex Index
• Category: Sector
• Focus: Health Care
• Development Level: Developed Markets
• Region: North America
• Number of Holdings: 33

Fund Statistics

• Assets Under Management: $240.11 million
• Average Daily Volume: $10,331.00
• Discount/Premium: -0.04%

Administrator, Advisor and Custodian

• Administrator: The Bank of New York Mellon Corporation
• Advisor: Invesco Capital Management LLC
• Custodian: The Bank of New York Mellon Corporation
• Distributor: Invesco Distributors, Inc.
• Transfer Agent: The Bank of New York Mellon Corporation
• Trustee: N/A
• Lead Market Maker: Citadel

Options

• Optionable: N/A
• Short Interest: 15,500 shs

Miscellaneous

• Outstanding Shares: 2,960,000
• Beta: 0.51
• Creation Unit: 10,000
• Creation Fee: $500.00